Altimmune is a clinical stage biopharmaceutical company based in Gaithersburg, MD, focused on developing next-generation peptide therapeutics for obesity and liver disease. Their pipeline includes Pemvidutide for obesity and non-alcoholic steatohepatitis (NASH), as well as HepTcell for chronic hepatitis B.
The company's innovative programs aim to address significant unmet medical needs in the field of peptide-based therapeutics, with a commitment to advancing treatments for complex metabolic and liver conditions. Altimmune's dedication to research and development is evident through their partnerships, clinical trials, and investor relations.
Generated from the website